| Synonym | Dasatinib R, BMS-354825 Monohydrate, N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide hydrate, Dasatinib monohydrate N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide monohydrate, Dasatinib monohydrate, >=99%, 5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-, hydrate (1:1), dasatinib monohydrate, n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide monohydrate, BMS 35482503, BMS-354825-03, Dasatinib, Dasatinib hydrate, N-(2-Chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide hydrate, Sprycel, UNII-RBZ1571X5H, Systematic Name 5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-, monohydrate, Registry Numbers CAS Registry Number 863127-77-9, FDA UNII RBZ1571X5H, System Generated Number 0863127779, Molecular Formulas ?Molecular Formula C22-H26-Cl-N7-O2-S.H2-O, Molecular Formula Fragments C22-H26-Cl-N7-O2-S, COMPONENT, H2-O |
